FDA Considering Drug/Companion IVD Review Policy | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – The US Food and Drug Administration expects that companies developing drugs or in vitro companion diagnostic tests that depend on each other will file applications for the drug and the test concurrently, according to a guidance document FDA is still developing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.